Zhong Lun and Ropes & Gray advised LianBio on the deal. LianBio executed an initial public offering and listing of American depositary shares on the Nasdaq...
LianBio’s $325 Million Initial Public Offering
Transcenta’s HK$645 Million Initial Public Offering
Zhong Lun, working alongside Walkers and Skadden, Arps, Slate, Meagher & Flom LLP, advised Transcenta Holding Limited in connection with the initial public offering and listing...
CARsgen Therapeutics Holdings Limited’s Listing on the Stock Exchange of Hong Kong
Davis Polk and Maples and Calder advised CARsgen Therapeutics Holdings Limited, while Herbert Smith Freehills and Zhong Lun advised Goldman Sachs and UBS on the deal....